The role of the assessment of cystatin C, tau protein and beta-amyloid in the cerebrospinal fluid of patients with relapsing-remitting multiple sclerosis

被引：0
|
作者：
Mares, J
Kanovsky, P
Herzig, R
Urbanek, K
Hlustik, P
Vranova, H
Sklenarova, J
Bekarek, V
Schneiderka, P
Podivinsky, J
Vavrouskova, J
Stejskal, D
Adamova, K
Zapletalova, J
机构：
[1] Univ Hosp, Olomouc, Czech Republic
[2] Neurol Inst, Moravsky Beroun, Czech Republic
[3] Hosp Sternberk, Sternberk, Czech Republic
[4] Palacky Univ, CR-77147 Olomouc, Czech Republic
来源：
MULTIPLE SCLEROSIS JOURNAL | 2005年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S23 / S24
页数：2
相关论文
共 50 条
  • [21] Serum and saliva total tau protein as a marker for relapsing-remitting multiple sclerosis
    Mirzaii-Dizgah, Mohammad-Hossein
    Mirzaii-Dizgah, Mohammad-Reza
    Mirzaii-Dizgah, Iraj
    MEDICAL HYPOTHESES, 2020, 135
  • [22] Biochemical Differences in Cerebrospinal Fluid between Secondary Progressive and Relapsing-Remitting Multiple Sclerosis
    Herman, Stephanie
    Akerfeldt, Torbjorn
    Spjuth, Ola
    Burman, Joachim
    Kultima, Kim
    CELLS, 2019, 8 (02)
  • [23] Increased prevalence of and gene transcription by Chlamydia pneumoniae in cerebrospinal fluid of patients with relapsing-remitting multiple sclerosis
    T. Dong-Si
    J. Weber
    Y. B. Liu
    C. Buhmann
    H. Bauer
    C. Bendl
    P. Schnitzler
    C. Grond-Ginsbach
    A. J. Grau
    Journal of Neurology, 2004, 251 : 542 - 547
  • [24] Increased prevalence of and gene transcription by Chlamydia pneumoniae in cerebrospinal fluid of patients with relapsing-remitting multiple sclerosis
    Dong-Si, T
    Weber, J
    Liu, YB
    Buhmann, C
    Bauer, H
    Bendl, C
    Schnitzler, P
    Grond-Ginsbach, C
    Grau, AJ
    JOURNAL OF NEUROLOGY, 2004, 251 (05) : 542 - 547
  • [25] Secretory Phospholipase A2 activity in serum and cerebrospinal fluid of patients with relapsing-remitting multiple sclerosis
    Siroos, Bahaadin
    Balood, Mohammad
    Zahednasab, Hamid
    Mesbah-Namin, Seyed Alireza
    Pourgholy, Fatemeh
    Harirchian, Mohammad Hossein
    JOURNAL OF NEUROIMMUNOLOGY, 2013, 262 (1-2) : 125 - 127
  • [26] Proteomic analysis of cerebrospinal fluid for relapsing-remitting multiple sclerosis and clinically isolated syndrome
    Pavelek, Zbysek
    Vysata, Oldrich
    Tambor, Vojtech
    Pimkova, Kristyna
    Dai Long Vu
    Kuca, Kamil
    Stourac, Pavel
    Valis, Martin
    BIOMEDICAL REPORTS, 2016, 5 (01) : 35 - 40
  • [27] Cerebrospinal fluid analysis differentiates between relapsing-remitting and secondary progressive multiple sclerosis
    Jongen, PJH
    Lamers, KJB
    Doesburg, WH
    Lemmens, WAJG
    Hommes, OR
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1997, 63 (04): : 446 - 451
  • [28] Cholesterol levels in plasma and cerebrospinal fluid in patients with clinically isolated syndrome and relapsing-remitting multiple sclerosis
    Evangelopoulos, Maria-Eleftheria
    Koutsis, Georgios
    Boufidou, Fotini
    Markianos, Manolis
    NEUROBIOLOGY OF DISEASE, 2022, 174
  • [29] Serum and cerebrospinal fluid nitrite and nitrate levels in relapsing-remitting and secondary progressive multiple sclerosis patients
    Yuceyar, N
    Taskiran, D
    Sagduyu, A
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2001, 103 (04) : 206 - 211
  • [30] Impact of discontinuing interferon beta in patients with relapsing-remitting multiple sclerosis
    Agiela, Mabroka I. M.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 (06) : NP5 - NP5
12345